20 May, 2022 08:22 AM
SYDNEY, AUSTRALIA – 20 May 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related imm...read more
18 May, 2022 08:17 AM
SYDNEY, AUSTRALIA – 18 May 2022 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel LAG-3-related imm...read more
29 Apr, 2022 10:18 AM
* Collaboration with the University of Queensland (UQ) expanded to develop a worldfirst exosome-based ovarian cancer screening test
* ResearchDx, a US-based specialty contract diagnostics organisat...read more